CYTB323K12201
Clinical Trial Grant
Administered By
Pediatrics, Transplant and Cellular Therapy
Awarded By
Novartis Pharmaceuticals Corporation
Start Date
January 14, 2026
End Date
March 31, 2030
Administered By
Pediatrics, Transplant and Cellular Therapy
Awarded By
Novartis Pharmaceuticals Corporation
Start Date
January 14, 2026
End Date
March 31, 2030